LIPODERMA Trademark

Trademark Overview


On Wednesday, October 9, 2024, a trademark application was filed for LIPODERMA with the United States Patent and Trademark Office. The USPTO has given the LIPODERMA trademark a serial number of 98792318. The federal status of this trademark filing is STATEMENT OF USE - TO EXAMINER as of Tuesday, September 16, 2025. This trademark is owned by Britecyte Inc.. The LIPODERMA trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
lipoderma

General Information


Serial Number98792318
Word MarkLIPODERMA
Filing DateWednesday, October 9, 2024
Status748 - STATEMENT OF USE - TO EXAMINER
Status DateTuesday, September 16, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements


Goods and ServicesHuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 9, 2024
Primary Code005
First Use Anywhere DateMonday, April 14, 2025
First Use In Commerce DateMonday, April 14, 2025

Trademark Owner History


Party NameBritecyte Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703

Party NameBritecyte Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703

Trademark Events


Event DateEvent Description
Wednesday, October 9, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 21, 2024ASSIGNED TO EXAMINER
Wednesday, October 9, 2024NEW APPLICATION ENTERED
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, April 23, 2025USE AMENDMENT FILED
Wednesday, April 23, 2025TEAS STATEMENT OF USE RECEIVED
Tuesday, September 16, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, September 16, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords


lipoderma tissue allograft human